Q2 2025 Highlights
"Kinnevik concludes a solid second quarter with strong growth and
continued margin improvements in our core companies. We also continue
to selectively add exciting companies to our portfolio and in the quarter
we led a funding round in Tandem Health. We are proud to partner with
a Swedish company at the intersection of healthcare, SaaS and AI, as it
pioneers the next generation of healthcare infrastructure in Europe."
Georgi Ganev, CEO of Kinnevik
Kinnevik in numbers
36.8
Net Asset Value, SEKbn
133
NAV per share
+2%
Change in NAV Q/Q
9.6
Net Cash Position, SEKbn
(6)%
Change in NAV Y/Y
(4)%
On Year Total Shareholder Return
Conference Call 10am CET
Welcome to listed to the conference call presenting the results.
(listen only)
Those who wish to participate in the teleconference are welcome to register via the below link. Participants will receive dial-in numbers and confirmation code upon registration. Please make sure to register and dial in a few minutes before the teleconference begins.
(for participants)